Related Experiment Video
Updated: Mar 21, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Long-term outcomes in patients with rheumatologic disorders undergoing percutaneous coronary intervention: a BAsel
Kotaro Nochioka1, Tor Biering-Sørensen2, Kim Wadt Hansen3
11 Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Clinical Research, Innovation and Education Center, Tohoku University Hospital, Sendai, Japan.
Insights
Patients with rheumatologic disorders undergoing percutaneous coronary intervention (PCI) face a higher risk of major adverse cardiac events (MACEs), including cardiac death and myocardial infarction. This highlights the need for focused care in this high-risk population post-PCI.
Area of Science:
- Cardiology
- Rheumatology
- Interventional Cardiology
Background:
- Rheumatologic disorders are linked to increased coronary artery disease (CAD) risk due to inflammation.
- The long-term prognosis of CAD patients with rheumatologic disorders after percutaneous coronary intervention (PCI) remains unclear.
Purpose of the Study:
- To investigate the association between rheumatologic disorders and the long-term prognosis of patients with CAD undergoing PCI.
Main Methods:
- A post-hoc analysis of 4605 patients from the BASKET-PROVE I and II trials was conducted.
- Patients with ST-segment elevation myocardial infarction (STEMI), non-STEMI, and stable CAD were evaluated.
- Cox regression analysis assessed the association between rheumatologic disorders and 2-year major adverse cardiac events (MACEs), including cardiac death, nonfatal myocardial infarction (MI), and target vessel revascularisation (TVR).
Main Results:
- Patients with rheumatologic disorders (n=197) were older, more often female, and had higher rates of renal disease and multi-vessel CAD.
- The overall 2-year MACE rate was 8.6%.
- Rheumatologic disorders were independently associated with MACEs (adjusted hazard ratio [aHR]: 1.55), driven by the STEMI subgroup (aHR: 2.38). These disorders also correlated with all-cause death (aHR: 2.05), cardiac death (aHR: 2.63), and non-fatal MI (aHR: 2.64), but not TVR (aHR: 0.81).
Conclusions:
- Rheumatologic disorders are independently associated with worse long-term outcomes in CAD patients following PCI.
- This finding underscores the importance of identifying and managing this high-risk patient group.
- Further research is warranted to optimize care for rheumatologic patients undergoing PCI.
Aims:
Rheumatologic disorders are characterised by inflammation and an increased risk of coronary artery disease (CAD). However, the association between rheumatologic disorders and long-term prognosis in CAD patients undergoing percutaneous coronary intervention (PCI) is unknown. Thus, we aimed to examine the association between rheumatologic disorders and long-term prognosis in CAD patients undergoing PCI.
Methods And Results:
A post-hoc analysis was performed in 4605 patients (age: 63.3 ± 11.0 years; male: 76.6%) with ST-segment elevation myocardial infarction (STEMI; n = 1396), non-STEMI ( n = 1541), and stable CAD ( n = 1668) from the all-comer stent trials, the BAsel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination (BASKET-PROVE) I and II trials. We evaluated the association between rheumatologic disorders and 2-year major adverse cardiac events (MACEs; cardiac death, nonfatal myocardial infarction (MI), and target vessel revascularisation (TVR)) by Cox regression analysis. Patients with rheumatologic disorders ( n = 197) were older, more often female, had a higher prevalence of renal disease, multi-vessel coronary disease, and bifurcation lesions, and had longer total stent lengths. During the 2-year follow-up, the MACE rate was 8.6% in the total cohort. After adjustment for potential confounders, rheumatologic disorders were associated with MACEs in the total cohort (adjusted hazard ratio: 1.55; 95% confidence interval (CI): 1.04-2.31) driven by the STEMI subgroup (adjusted hazard ratio: 2.38; 95% CI: 1.26-4.51). In all patients, rheumatologic disorders were associated with all-cause death (adjusted hazard ratio: 2.05; 95% CI: 1.14-3.70), cardiac death (adjusted hazard ratio: 2.63; 95% CI: 1.27-5.43), and non-fatal MI (adjusted hazard ratio: 2.64; 95% CI: 1.36-5.13), but not with TVR (adjusted hazard ratio: 0.81; 95% CI: 0.41-1.58).
Conclusions:
The presence of rheumatologic disorders appears to be independently associated with worse outcome in CAD patients undergoing PCI. This calls for further studies and focus on this high-risk group of patients following PCI.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Rheumatic Heart Disease I: Introduction
Pericarditis III: Medical Management